Menu Search
Equities

Kewaunee Scientific Corp

KEQU:NMQ

Kewaunee Scientific Corp

Actions
Consumer DiscretionaryHousehold Goods and Home Construction
  • Price (USD)42.30
  • Today's Change-0.28 / -0.66%
  • Shares traded14.94k
  • 1 Year change+138.17%
  • Beta0.7796
Data delayed at least 15 minutes, as of Nov 21 2024 20:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Kewaunee Scientific Corp had revenues fall -7.17% from 219.49m to 203.76m, though the company grew net income 2,441.06% from 738.00k to 18.75m.
Gross margin26.01%
Net profit margin9.28%
Operating margin8.43%
Return on assets14.62%
Return on equity38.70%
Return on investment21.67%
More ▼

Cash flow in USDView more

In 2024, Kewaunee Scientific Corp increased its cash reserves by 87.75%, or 12.12m. The company earned 19.56m from its operations for a Cash Flow Margin of 9.60%. In addition the company used 4.37m on investing activities and also paid 3.01m in financing cash flows.
Cash flow per share7.44
Price/Cash flow per share5.56
Book value per share19.51
Tangible book value per share19.51
More ▼

Balance sheet in USDView more

Kewaunee Scientific Corp has a Debt to Total Capital ratio of 35.69%, a lower figure than the previous year's 71.27%.
Current ratio2.53
Quick ratio2.00
Total debt/total equity0.5698
Total debt/total capital0.3569
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 2,409.89%. Additionally, five year annualized earnings per share growth ranks above the industry average relative to its peers.
EPS growth(5 years)61.89
EPS (TTM) vs
TTM 1 year ago		365.16
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.